Chatbots are far more predictable in their responses than you might expect. That's fine for research or coding, but it's a ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

Buy: Anthropic exposure via its likely IPO/secondary path (e.g., IPO allocation or liquid proxy like AI-safety/compute beneficiaries). Rationale: Anthropic is pushing “slow/pause” policy while still ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Best Penny Stocks with Huge Upside Potential. On May 14, Morgan Stanley raised the price target on Recursion Pharmaceuticals, Inc.

I was 11 years old when I learned that I talk funny. A new teacher who didn’t share my Boston accent was surprised by the way I said “kindergarten.” She mockingly repeated my pronunciation back to me: ...

Has anyone ever poked fun at the way you talk, how you pronounce a word or phrase? For Philadelphians, it might be “wooder” “caw-fee” “bee-yoo-dee-full” or “jeet?” But all of us have some kind of ...

In “Why Do We Exist?” Hakeem Oluseyi explores how life may have emerged to move energy through matter—and why Earth is the perfect setting. The following is an excerpt from “Why Do We Exist?: The Nine ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to supercharge its AI-driven drug discovery platform through an expanded ...

Joe Supan is a senior writer for CNET covering home technology, broadband, and moving. Prior to joining CNET, Joe led MyMove's moving coverage and reported on broadband policy, the digital divide, and ...